The US Food and Drug Administration approved AbbVie’s treatment for Parkinson’s disease, three months ahead of the scheduled review date.The treatment(...)

Shire’s  offices at Citywest Business Campus, Dublin: the Footsie 100 Shire group is looking to build its pipeline of standalone speciality drugs. Photograph: Aidan Crawley/Bloomberg

Shire, the Irish-headquartered drugmaker, has made its biggest ever acquisition with a $5.2 billion deal for US biotechnology company NPS Pharmaceutic(...)

In 1966, scientists made a huge breakthrough in nanomedicine. They found they could miniaturise a submarine and its crew and inject it into a patient’(...)

Have you ever felt you needed to see a psychiatrist about your coffee-drinking habits? Thought not. But “caffeine-related disorders” are now includ(...)

A customer puffs on an e-cigarette at the Henley Vaporium in New York City. Photograph: Mike Segar/Reuters

The Health Services Executive is to ban the use of electronic cigarettes in all health service facilities from next month. The decision w(...)

Alkermes chief executive Richard Pops. Photograph: Dara Mac Dónaill / THE IRISH TIMES

Shares in Irish drug company Alkermes jumped over 10 per cent yesterday after it announced plans to seek US marketing approval for its experime(...)

It seems strange that GSK allowed events to culminate in a warning letter: its sense of urgency now in dealing with the problems is welcome.

Tomorrow is the deadline for GlaxosmithKline to inform the US Food and Drug Administration how it intends to ensure compliance with quality st(...)

GSK Ireland spokeswoman said last night that the company had triggered a product recall of the affected batches. Photograph: Getty

GlaxosmithKline has announced a product recall after the US Food and Drug Administration published a warning letter over conta(...)

ICON says its acquisition of Aptiv Solutions will enhance its capabilities in adaptive and medical device trials and in Japan.

Icon, the Dublin based provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has agreed t(...)

PTC Therapeutics said a committee of the European Medicines Agency recommended against a conditional approval to its drug for the treatment of a rare (...)